Demetrios G Vavvas Selected Research

Lasers (Laser)

11/2019	RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization.
7/2012	The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Demetrios G Vavvas Research Topics

Disease

24	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 01/2011
17	Retinal Detachment (Retinal Detachments) 01/2024 - 12/2010
7	Inflammation (Inflammations) 01/2023 - 08/2011
7	Atrophy 01/2023 - 05/2012
6	Necrosis 12/2022 - 12/2010
6	Neoplasms (Cancer) 01/2021 - 01/2013
5	Geographic Atrophy 05/2024 - 06/2021
5	Retinal Degeneration 01/2024 - 09/2012
4	Retinal Perforations 09/2023 - 01/2014
4	Epiretinal Membrane (Epiretinal Membranes) 09/2023 - 01/2014
4	Wounds and Injuries (Trauma) 07/2023 - 04/2014
4	Burns 07/2023 - 04/2014
4	Uveal melanoma 01/2023 - 04/2014
4	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2022 - 01/2016
4	Eye Diseases (Eye Disease) 01/2022 - 01/2016
4	Retinoblastoma (Glioblastoma, Retinal) 12/2014 - 08/2010
3	Retinal Vein Occlusion 03/2024 - 04/2022
3	Corneal Neovascularization 07/2023 - 07/2012
3	Melanoma (Melanoma, Malignant) 01/2023 - 10/2019
3	Blindness (Hysterical Blindness) 11/2022 - 01/2014
3	Choroidal Neovascularization 05/2022 - 07/2012
3	Infections 05/2022 - 01/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
3	Glaucoma 02/2018 - 01/2012
2	Vitreous Detachment (Posterior Vitreous Detachment) 09/2023 - 01/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2022
2	Neuroinflammatory Diseases 01/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2016
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 12/2021 - 03/2013
2	Retinal Diseases 01/2021 - 09/2012
2	Retinitis 10/2020 - 09/2012
2	Pathologic Neovascularization 11/2019 - 01/2014
2	Atherosclerosis 03/2016 - 01/2016
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2012 - 06/2011
2	Uveitis 06/2012 - 08/2011
1	Retinoschisis (Retinoschisis, Juvenile) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 09/2023
1	Macular Edema 09/2023
1	Kidney Diseases (Kidney Disease) 09/2023
1	Vascular Diseases (Vascular Disease) 07/2023
1	Myopia 01/2023
1	Cataract (Cataracts) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Epilepsy (Aura) 01/2023

Drug/Important Bio-Agent (IBA)

25	Retinaldehyde (Retinal)IBA 01/2024 - 12/2010
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024 - 07/2012
7	Phosphotransferases (Kinase)IBA 11/2019 - 08/2010
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2011
5	AlkaliesIBA 07/2023 - 04/2014
5	Complement System Proteins (Complement)IBA 07/2023 - 01/2020
5	AICA ribonucleotide (ZMP)IBA 04/2014 - 08/2010
4	LipidsIBA 01/2024 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
4	Protein Kinases (Protein Kinase)IBA 01/2023 - 12/2010
4	Verteporfin (Visudyne)FDA Link 01/2021 - 07/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2012
3	InflammasomesIBA 01/2023 - 11/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 03/2016
3	CytokinesIBA 02/2018 - 04/2014
3	Hyaluronic Acid (Hyaluronan)IBA 05/2014 - 01/2011
3	Adenosine Monophosphate (AMP)IBA 04/2014 - 08/2010
3	Receptor-Interacting Protein Serine-Threonine KinasesIBA 09/2012 - 12/2010
3	CaspasesIBA 06/2011 - 12/2010
2	CholesterolIBA 01/2024 - 01/2016
2	Silicone OilsIBA 01/2024 - 09/2014
2	Thioctic Acid (Lipoic Acid)IBA 01/2023 - 01/2022
2	IronIBA 01/2023 - 01/2019
2	ProdrugsIBA 01/2023 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2020
2	afliberceptIBA 12/2021 - 07/2013
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 10/2020
2	necrostatin-1IBA 11/2019 - 07/2014
2	Indicators and Reagents (Reagents)IBA 10/2019 - 11/2018
2	AntioxidantsIBA 01/2018 - 01/2017
2	CyclinsIBA 04/2014 - 01/2013
1	pegcetacoplanIBA 05/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2023
1	semaglutideIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 09/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 09/2023
1	PPAR-gamma AgonistsIBA 09/2023
1	Trace Elements (Biometals)IBA 01/2023
1	Selenoproteins (Selenoprotein)IBA 01/2023
1	SeleniumIBA 01/2023
1	InterleukinsIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Nerve Growth Factors (Neurotrophins)IBA 12/2022

Therapy/Procedure

9	Therapeutics 05/2022 - 01/2014
7	Vitrectomy 01/2024 - 01/2014
3	Traction 09/2023 - 01/2014
2	Injections 03/2024 - 01/2020
2	Lasers (Laser) 11/2019 - 07/2012
2	Intraperitoneal Injections 11/2016 - 01/2013
2	Vitreoretinal Surgery 09/2014 - 01/2014
1	Phacoemulsification 01/2023
1	Low-Level Light Therapy (LLLT) 01/2023
1	Vagus Nerve Stimulation 01/2023
1	Transplantation 01/2023
1	Transcranial Magnetic Stimulation 01/2023
1	Postoperative Care 11/2022